CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $400,176 | -30.1% | 95,280 | 0.0% | 0.31% | -34.1% |
| Q4 2022 | $572,633 | +3.2% | 95,280 | 0.0% | 0.47% | -5.6% |
| Q3 2022 | $555,000 | -5.0% | 95,280 | -2.6% | 0.50% | +0.2% |
| Q2 2022 | $584,000 | +27.8% | 97,780 | 0.0% | 0.50% | +43.8% |
| Q1 2022 | $457,000 | +88.8% | 97,780 | 0.0% | 0.34% | +93.8% |
| Q4 2021 | $242,000 | – | 97,780 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |